Recommendations for the management of patients after heart valve surgery.

@article{Butchart2005RecommendationsFT,
  title={Recommendations for the management of patients after heart valve surgery.},
  author={E. Butchart and C. Gohlke-B{\"a}rwolf and M. Antunes and P. Tornos and R. De Caterina and B. Cormier and B. Prendergast and B. Iung and H. Bj{\o}rnstad and C. Leport and R. Hall and A. Vahanian},
  journal={European heart journal},
  year={2005},
  volume={26 22},
  pages={
          2463-71
        }
}
Approximately 50,000 valve replacement operations take place in Europe annually and almost as many valve repair procedures. Previous European guidelines on management of patients after valve surgery were last published in 1995 and were limited to recommendations about antithrombotic prophylaxis. American guidelines covering the broader topic of the investigation and treatment of patients with valve disease were published in 1998 but devoted relatively little space to post-surgical management… Expand

Paper Mentions

Interventional Clinical Trial
In this prospective, controlled trial, patient after TAVI will be randomized to either exercise training or usual care group.  
ConditionsAortic Valve Stenosis, Rehabilitation, TAVI, (+1 more)
InterventionOther
Antithrombotic management in patients with prosthetic valves: a comparison of American and European guidelines
TLDR
Although both guidelines agree that individual patient risk assessment is important, the American guidelines utilise this only to adjust anticoagulation and/or antiplatelet therapy, whereas the European guidelines emphasise the importance of risk factor reduction or treatment as an essential component of overall antithrombotic management. Expand
Oral anticoagulation after isolated aortic valve replacement
TLDR
The case of a patients who was referred to the cardiology department for inpatient exercise based cardiac rehabilitation after aortic valve replacement and who was treated successfully with special emphases on anticoagulant therapy choice and patient education is presented. Expand
[Management of patients with prosthetic heart valves].
TLDR
It is the cardiologist's responsibility to define the patients' antithrombotic treatment regimen and to guide the patients through special situations like gravidity or before and after an operation. Expand
Follow-up and management of valvular heart disease patients with prosthetic valve: a clinical practice guideline for Indian scenario
TLDR
Anticoagulant therapy with VKA seems to be an effective option post prosthetic valve implantation in VHD patients, however, the role for non-VKA oral therapy in prosthetics valve patients and the safety and efficacy of novel oral anticoagULants in patients with bioprosthetic valve need to be studied extensively. Expand
Should warfarin be routinely prescribed for the first three months after a bioprosthetic valve replacement?
TLDR
All guidelines, the available evidence and current practice support the use of warfarin at an INR of 2-3 for 3 months for bioprosthetic mitral valve replacement (MVR), and it is certainly safe to use antiplatelet therapy alone post-bioprosthetics AVR. Expand
Is short-term anticoagulation necessary after mitral valve repair?
TLDR
It is concluded that the current European Society of Cardiology guidelines support the use of warfarin for 3 months post-mitral repair, citing an absence of studies supporting the safety of omittingwarfarin. Expand
Treatment of prosthetic valve thrombosis: rationale for a prospective randomized clinical trial.
TLDR
The management of PVT remains controversial, and a prospective randomized clinical trial is required, and this could be achieved by developing an international database for patient enrollment and randomization into available treatment strategies. Expand
Improving the quality of anticoagulant therapy in patients with mechanical heart valves: what are we waiting for?
The replacement of destroyed heart valves by mechanical, thrombogenic prostheses would be hard to imagine without the availability of anticoagulant treatment. Coumarins were introduced in clinicalExpand
Antithrombotic therapy following bioprosthetic aortic valve replacement.
TLDR
There is division of opinion and practice, despite recommendations, and more recent studies have not supported the evidence for these guidelines, on the use of anticoagulation in the first 90 days following bioprosthetic AVR. Expand
What is the optimal level of anticoagulation in adult patients receiving warfarin following implantation of a mechanical prosthetic mitral valve?
TLDR
It is concluded that after implantation of new generation prosthetic mechanical mitral valves, patients should receive warfarin to a target INR of 2.5-3.5, ensuring lowest possible variation in the intensity of anticoagulation in patients with a history of thromboembolic disease and/or coronary artery disease. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 112 REFERENCES
Recommendations on the management of the asymptomatic patient with valvular heart disease.
TLDR
The Working Group on Valvular Heart Disease of the European Society of Cardiology have produced these recommendations, which address the management of asymptomatic patients with valvular heart disease and the major types of acquired valve disease. Expand
Anticoagulation in valvar heart disease: new aspects and management during non-cardiac surgery
The indications for oral anticoagulant treatment have been extended over the last 10 years. The detection of new congenital thrombophilic risk factors, the studies on non-valvar atrial fibrillation,Expand
Better anticoagulation control improves survival after valve replacement.
TLDR
High anticoagulation variability is the most important independent predictor of reduced survival after valve replacement with a mechanical valve, and better antICOagulation control should improve survival. Expand
AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves.
TLDR
In selected patients with mechanical prostheses, moderate anticoagulation prevents thromboembolic events as effectively as conventional anticoAGulation and reduces the incidence of hemorrhagic events. Expand
Risk, diagnosis and management of prosthetic valve endocarditis: a review.
TLDR
An algorithm is set forth for diagnosis and management of patients with suspected PVE based on personal experience and the published literature, and indications for surgery, the surgical approach and methods of PVE prophylaxis and prevention are discussed. Expand
The St. Jude Valve Thrombolysis as the First Line of Therapy for Cardiac Valve Thrombosis
TLDR
Thrombolytic therapy can be used as the first line of therapy for thrombosed St. Jude valves with a low risk of permanent side effects and excellent chances of success. Expand
Comparing Warfarin With Aspirin After Biological Aortic Valve Replacement: A Prospective Study
TLDR
There seem to be no advantages in performing early anticoagulation therapy compared with a low-antiplatelet regimen with regard to early cerebral ischemic events, bleeding, and survival. Expand
Clinical significance of early thrombosis after prosthetic mitral valve replacement: a postoperative monocentric study of 680 patients.
TLDR
This study confirms the incidence of early thrombi after mechanical mitral valve replacement detected by TEE, and a small (<5 mm) nonobstructive thrombus seems benign, and the experience argues in favor of medical treatment. Expand
The role of thrombolysis in the management of left-sided prosthetic valve thrombosis: a study of 85 cases diagnosed by transesophageal echocardiography.
TLDR
Thrombolysis was shown to be superior to surgery in obstructive PVT, especially in NYHA class IV patients, and heparin treatment appeared ineffective and unsafe for the treatment of PVT. Expand
The Ross procedure: long-term clinical and echocardiographic follow-up.
TLDR
Long-term follow-up of patients with the Ross procedure using the root replacement technique indicates excellent survival and low thromboembolic and endocarditis risk, and periodic follow- up with echocardiography is recommended because of the continuing risk of progressive regurgitation of the neo-aortic valve and aneurysm formation. Expand
...
1
2
3
4
5
...